A Comprehensive Study of Repetitive Transcranial Magnetic Stimulation in Parkinson's Disease

The clinical benefits of repetitive transcranial magnetic stimulation (rTMS) for Parkinson's disease (PD) remain controversial. We performed a comprehensive study to examine whether rTMS is a safe and effective treatment for PD. Twelve PD patients received rTMS once a week. The crossover study design consisted of 4-week sham rTMS followed by 4-week real rTMS. The Unified Parkinson's Disease Rating Scale (UPDRS), Modified Hoehn and Yahr Stage, Schwab and England ADL Scale, Actigraph, Mini-Mental State Examination, Hamilton Depression Scale, Wechsler Adult Intelligence Scale-revised, and cerebral blood flow (CBF) and cerebrospinal fluid (CSF) examinations were used to evaluate the rTMS effects. Under both drug-on and drug-off conditions, the real rTMS improved the UPDRS scores significantly, while the sham rTMS did not. There were no significant changes in the results of the neuropsychological tests, CBF and CSF. rTMS seems to be a safe and effective therapeutic option for PD patients, especially in a wearing-off state

0.54 μm resolution two-photon interference with dispersion cancellation for quantum optical coherence tomography.

量子もつれ光を用いた、超高分解能光断層撮影技術を開発-. 京都大学プレスリリース. 2015-12-15.Quantum information technologies harness the intrinsic nature of quantum theory to beat the limitations of the classical methods for information processing and communication. Recently, the application of quantum features to metrology has attracted much attention. Quantum optical coherence tomography (QOCT), which utilizes two-photon interference between entangled photon pairs, is a promising approach to overcome the problem with optical coherence tomography (OCT): As the resolution of OCT becomes higher, degradation of the resolution due to dispersion within the medium becomes more critical. Here we report on the realization of 0.54 μm resolution two-photon interference, which surpasses the current record resolution 0.75 μm of low-coherence interference for OCT. In addition, the resolution for QOCT showed almost no change against the dispersion of a 1 mm thickness of water inserted in the optical path, whereas the resolution for OCT dramatically degrades. For this experiment, a highly-efficient chirped quasi-phase-matched lithium tantalate device was developed using a novel 'nano-electrode-poling' technique. The results presented here represent a breakthrough for the realization of quantum protocols, including QOCT, quantum clock synchronization, and more. Our work will open up possibilities for medical and biological applications

Noncollinear parametric fluorescence by chirped quasi-phase matching for monocycle temporal entanglement

Quantum entanglement of two photons created by spontaneous parametric downconversion (SPDC) can be used to probe quantum optical phenomena during a single cycle of light. Harris [Opt. Express 98, 063602 (2007)] suggested using ultrabroad parametric fluorescence generated from a quasi-phase-matched (QPM) device whose poling period is chirped. In the Harris's original proposal, it is assumed that the photons are collinearly generated and then spatially separated by frequency filtering. Here, we alternatively propose using noncollinearly generated SPDC. In our numerical calculation, to achieve 1.2 cycle temporal correlation for a 532 nm pump laser, only 10%-chirped device is sufficient when noncollinear condition is applied, while a largely chirped (50%) device is required in collinear condition. We also experimentally demonstrate an octave-spanning (790-1610 nm) noncollinear parametric fluorescence from a 10% chirped MgSLT crystal using both a superconducting nanowire single-photon detector and photomultiplier tube as photon detectors. The observed SPDC bandwidth is 194 THz, which is the largest width achieved to date for a chirped QPM device. From this experimental result, our numerical analysis predicts that the bi-photon can be compressed to 1.2 cycles with appropriate phase compensation

Epidemic Myalgia in Adults Associated with Human Parechovirus Type 3 Infection, Yamagata, Japan, 2008

Human parechovirus has rarely been shown to cause clinical disease in adults. During June–August 2008, a total of 22 adults sought treatment at Yonezawa City Hospital in Yamagata, Japan, for muscle pain and weakness of all limbs; most also had fever and sore throat. All patients received a clinical diagnosis of epidemic myalgia; clinical laboratory findings suggested an acute inflammatory process. Laboratory confirmation of infection with human parechovirus type 3 (HPeV3) was made for 14 patients; we isolated HPeV3 from 7 patients, detected HPeV3 genome in 11, and observed serologic confirmation of infection in 11. Although HPeV3 is typically associated with disease in young children, our results suggest that this outbreak of myalgia among adults was associated with HPeV3 infection. Clinical consideration should be given to HPeV3 not only in young children but also in adults when an outbreak occurs in the community